StockData
Lipocine Inc. logo

Lipocine Inc. (LPCN) stock

LPCNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3039% below fair value
$1.52−0.08 (-5.00%)

Close on Nov 18, 2026Market cap $12.53MP/E –Yield –

Lipocine price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Lipocine's price to sales ratio was 8.4× on Nov 11, 2026, against 4.3× a year earlier. Over the last 5 years it ranged from 1.5× to 376.0×, with a median of 11.6×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20268.4×−1.7
2025Dec 31, 202510.1×+6.8
2024Dec 31, 20243.3×−239.5
2023Oct 31, 2023242.8×+237.9
2022Apr 29, 20224.8×−121.5
2020Apr 30, 2020126.4×+68.0
2019Dec 31, 201958.4×−6.4
2018Dec 31, 201864.8×–

More Lipocine figures

See a number that looks wrong?